Abstract

Child-safety Containers/Devices and Compounding

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2017 - Volume 21, Number 5

Page(s): 364-370

Download in electronic PDF format for $75
  • Child-safety Containers/Devices and Compounding Page 1
  • Child-safety Containers/Devices and Compounding Page 2
  • Child-safety Containers/Devices and Compounding Page 3
  • Child-safety Containers/Devices and Compounding Page 4
  • Child-safety Containers/Devices and Compounding Page 5
  • Child-safety Containers/Devices and Compounding Page 6
  • Child-safety Containers/Devices and Compounding Page 7

Abstract

The U.S. Consumer Product Safety Commission has been around since it was created in 1972 through the Consumer Product Safety Act. Its purpose is to protect “against unreasonable risks of injuries associated with consumer products.” Manufactured drugs must meet the standards unless specifically exempted. Dispensing and compounding pharmacists must also meet the standards. Due to a smaller market size, compliant products to meet the U.S. Consumer Product Safety Commission’s standards to aid compounding pharmacists have been slow in coming. However, now there are numerous different products, some introduced recently, which make it easier for compounding pharmacists to comply with the standards. The new technologies are innovative and serve a great need.

Related Keywords

  • U.S. Consumer Product Safety Commission
  • drug packaging
  • child-resistant container
  • Poison Prevention Packaging Act
  • poisoning

Related Categories

  • HISTORY
  • LEGAL
  • PACKAGING

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2017
Pg. 364-370
Child-safety Containers/Devices and Compounding
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 451-458
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Author(s): Allen W Chris, Greeson Nicole MH, Mixon William
Jul/Aug 2003
Pg. 272-275
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention
Author(s): Stein Michael F, Parsons Eric
Jul/Aug 2021
Pg. 311-317
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 454-461
How to Qualify Container Closure Systems for Intended Use, Part 1
Author(s): Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
Jul/Aug 2020
Pg. 270-276
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Nov/Dec 2015
Pg. 491-500
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Author(s): Akers Michael J
Jan/Feb 2020
Pg. 14-19
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Author(s): Vaughn Stacey R, Radwick Allison
Sep/Oct 2021
Pg. 358-362
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Author(s): Cabaleiro Joe
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 182-190
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Author(s): Mixon Bill, Nain John
Sep/Oct 2020
Pg. 371-379
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Jul/Aug 2020
Pg. 287-295
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
Author(s): McElhiney Linda F
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Sep/Oct 2018
Pg. 358-366
Current Trends and Emerging Priorities in Compounded Preparations for Children
Author(s): Parrish Richard H II
Mar/Apr 2018
Pg. 92
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Author(s): Allen Loyd V Jr
Mar/Apr 2015
Pg. 104-106
Standing Together Fixing the Drug Quality and Security Act
Author(s): Miller David G
Sep/Oct 2021
Pg. 389-395
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Nov/Dec 2023
Pg. 474-481
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Author(s): Allen Loyd V Jr